Press Releases

MabVax Therapeutics and Oncotelic Enter into Merger Discussions

Jan 4, 2019

MabVax Therapeutics Engages Objective Capital as Advisor for Exploring Asset Sales

Dec 13, 2018

MabVax Therapeutics Holdings, Inc. Announces $1.0 Million Equity Purchase Agreement

Nov 28, 2018

MabVax Therapeutics Audited Financial Statements Reinstated

Oct 16, 2018

Delaware Court of Chancery Grants Petition Filed by MabVax Therapeutics

Sep 21, 2018

MabVax Therapeutics Files Suit Against Sichenzia Ross Ference LLP, a Law Firm that Formerly Represented the Company in Certain Corporate, Securities, and Securities and Exchange Commission Matters

Sep 11, 2018

MabVax Therapeutics Engages New Independent Auditor

Aug 23, 2018

MabVax Therapeutics Announces Auditor Resignation

Aug 8, 2018

Delaware Court of Chancery Sets Hearing Date On Petition Filed By MabVax Therapeutics

Aug 3, 2018

MabVax Therapeutics Announces Board of Director Changes

Aug 1, 2018